BioSpace News Archive

Business

Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific Officer

Lyell Immunopharma, Inc. today announced the appointment of Gary Lee, Ph.D., as Chief Scientific Officer.

January 31, 2022
·
5 min read
Business

Augmedix Announces Preliminary Fourth Quarter 2021 Financial Results

Augmedix, Inc. today announced preliminary unaudited financial and operational results for the three months ended December 31, 2021.

January 31, 2022
·
5 min read
Business

Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors

Replimune Group Inc. today announced Otello Stampacchia, Ph.D., of Omega Funds, has resigned from the company’s Board of Directors.

January 31, 2022
·
3 min read
Business

Tenax Therapeutics Appoints Robyn Hunter to the Board of Directors

Tenax Therapeutics, Inc. announced today that Tenax Therapeutics appointed Robyn Hunter to its Board of Directors, effective January 28, 2022.

January 31, 2022
·
6 min read
Business

Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call

Quotient Limited today announced that financial results for its fiscal third quarter ended December 31, 2021 will be released before market open on Tuesday, February 8, 2022.

January 31, 2022
·
1 min read
Business

U.S. Surgitech Announces Contract Agreement with Vizient

U.S. Surgitech Inc. has announced today that as of January 1, 2022 , they have been awarded a contract in the category of patient positioning with Vizient.

January 31, 2022
·
1 min read
Genetown

Decibel Therapeutics to Present at the 45th Annual Association for Research in Otolaryngology (ARO) Meeting

Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, announced today that it will present findings from its drug discovery and development programs at the 45th Annual MidWinter Meeting of the Association for Research in Otolaryngology (ARO).

January 31, 2022
·
2 min read
Genetown

Viridian Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Development of VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, today announced the United States Food and Drug Administration (FDA) clearance of its investigational new drug (IND) application of VRDN-002.

January 31, 2022
·
4 min read
Pharm Country

InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App

OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that its InteliSwab® COVID-19 rapid tests have been authorized by the U.S. Food and Drug Administration (FDA) for use in children ages 2 to 14. InteliSwab® was previously authorized for use in adults and in children 15 to 17 when administered by an adult.

January 31, 2022
·
10 min read
Business

Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients

Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, to develop a companion diagnostic to detect Dickkopf-related protein 1 (DKK1).

January 31, 2022
·
4 min read